Fig. 2

Comparison of clinical progression (Analysis-1). a PFS between patients in the anemia-ABI and non-anemia-ABI groups (Analysis-1) (median, not reached vs. 15 months; P < 0.001). b IPTW adjusted-multivariate logistic regression analyses for PFS in the upfront ABI group (adjustments for age, ECOG-PS, initial PSA, Gleason score, visceral metastasis, EOD, and ALP and LDH/Hb levels). Anemia (HR, 4.66; 95% CI, 1.36–16.0 P = 0.014). LDH level > 222 IU/L (HR, 2.68; 95% CI, 0.81–8.82 P = 0.105)